US · Healthcare · Medical Instruments & Supplies
EPS came in at 2.37 against a street estimate of 2.08 — a beat of 13.9%.
Analysts rate West Pharmaceutical Services Inc a strong buy (12 buy, 1 hold, 0 sell out of 13) with an average price target of $405.38.
| Fund | Stake |
|---|---|
| BlackRock Inc | 9.71% |
| Vanguard Capital Management, LLC | 6.65% |
| Vanguard Portfolio Management, LLC | 5.82% |
| State Street Corp | 4.68% |
| Bank of New York Mellon Corp | 3.50% |
| Artisan Partners Limited Partnership | 3.43% |
| T. Rowe Price Investment Management,Inc. | 3.33% |
| Generation Investment Management LLP | 2.88% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 WEST PHARMACEUTICAL SERVICES, INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Sales (6 months): $1,717.2 million vs. $1,464.5 million in 2025 (+1 | 2026-07-23 |
| Results announced · Q3 2026 WEST PHARMACEUTICAL SERVICES, INC. — Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 Net Sales: $872.3 million, up 13.8% reported and 12.7% orga | 2026-07-23 |
| Material agreement · Q3 2026 WEST PHARMACEUTICAL SERVICES, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Company entered into renewed agreements with Daikyo Seiko, Ltd. effective J | 2026-07-14 |
| Board / officer change · Q2 2026 WEST PHARMACEUTICAL SERVICES, INC. — FORM 8-K SUMMARY HEADLINE NUMBERS • New CEO compensation package total: approximately $28.7 million over initia | 2026-06-01 |
| Reg FD disclosure · Q2 2026 WEST PHARMACEUTICAL SERVICES, INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Material cybersecurity attack detected May 4, 2026; company formally determ | 2026-05-11 |
| Quarterly report · Q1 2026 WEST PHARMACEUTICAL SERVICES, INC. — Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net sales: $844.9 million (Q1 2026) vs. $698.0 million (Q1 2025) — incr | 2026-04-23 |
| Proxy statement · Q2 2026 WEST PHARMACEUTICAL SERVICES, INC. – PROXY SUMMARY FOR RETAIL INVESTORS CEO TOTAL COMPENSATION AND CHANGE • Eric M. Green (CEO) total compensation: | 2026-03-12 |
| Annual report FY2025 WEST PHARMACEUTICAL SERVICES, INC. – FORM 10-K SUMMARY HEADLINE NUMBERS • Market capitalization: $15.7 billion (as of June 30, 2025) • Outstanding s | 2026-02-17 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | $0.22 / share ex-date Jul 29, 2026 · pay Aug 5, 2026 | 2026-07-29 |
| Dividend | $0.22 / share ex-date Apr 29, 2026 · pay May 6, 2026 | 2026-04-29 |
| Dividend | $0.22 / share ex-date Jan 28, 2026 · pay Feb 4, 2026 | 2026-01-28 |
| Dividend | $0.22 / share ex-date Nov 12, 2025 · pay Nov 19, 2025 | 2025-11-12 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for West Pharmaceutical Services Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.